Product Information

AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2298 per EA under NDC 62332021430. Its NADAC has been published 458 times since Nov 15, 2017.

FDA first approved this application on Jul 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 10-20 MG

Amlodipine besylate and Olmesartran medoxomil
$0.2298per EA

Strength

10; 20 mg/1; mg/1

NDC

62332021430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207073

FDA Approved

7/17/2017

TE Code

AB

On Market Since

7/18/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 458 times since Nov 15, 2017, and over the history we have for it it has declined 76.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2298 per EA
All-time high$0.9674 (Aug 14, 2019)
All-time low$0.2298 (Aug 19, 2026)
52-week high$0.3713
52-week low$0.2298
Median price$0.4368
Average price$0.5045
Largest weekly change+68.6% (Nov 22, 2023)
Weeks tracked458
Tracking sinceNov 15, 2017

Price History

1W

-4.3%

1M

-4.3%

3M

-22.2%

6M

-27.6%

1Y

-38.1%

3Y

-49.7%

5Y

-59.2%

All

-76.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Alembic Pharmaceuticals Inc., is $0.2298 per EA (NDC 62332021430), effective Aug 19, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 76.1%. It has been tracked across 458 weekly CMS publications since Nov 15, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?

Since Nov 15, 2017, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2298 (Aug 19, 2026) to a high of $0.9674 (Aug 14, 2019), with a median of $0.4368 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-20 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?

AMLODIPINE-OLMESARTAN 10-20 MG (NDC 62332021430) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.